Gout: on the brink of novel therapeutic options for an ancient disease.
Bieber
Jeffry D
JD
Veterans Affairs Medical Center and University of California San Diego, San Diego, California 92161, USA.
Terkeltaub
Robert A
RA
D000208:Acute Disease; D001581:Benzothiadiazines; D004232:Diuretics; D005260:Female; D006073:Gout / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications; D033461:Hyperuricemia / Q000188:drug therapy; D007674:Kidney Diseases / Q000150:complications; D024821:Metabolic Syndrome / Q000150:complications; D009765:Obesity / Q000150:complications; D017698:Postmenopause; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D014503:Urate Oxidase / Q000627:therapeutic use; D014527:Uric Acid / Q000378:metabolism; D014528:Uricosuric Agents / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014528:Uricosuric Agents; D014527:Uric Acid; D014969:Xanthine Oxidase; D014503:Urate Oxidase